Total investments received (USD): 10.41m
Round value (USD): 10.41m
Round investors:
Meiji Seika Pharma
Company: Osivax




Netherlands
Austria
Germany
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain
United Kingdom